Mekhla Singhania presented work related to her thesis at the American Association of Cancer Research annual meeting in San Diego. Her abstract, titled “Enhancing Therapeutic Responses in NSCLC Using Iron-Oxide Nanoparticles Combined With Pharmacological Ascorbate” drew substantial interest among the attendees. Her thesis observed that combining high-dose vitamin C (ascorbate) with Ferumoxytol (an iron oxide nanoparticle) have demonstrated efficacy in selectively targeting non-small cell lung cancer cells. This research probes the effects of combining these therapies in the treatment of non-small cell lung cancer through an iron and hydrogen-peroxide dependent mechanism.